PDF herunterladen
J Neurol Surg Rep 2013; 74(01): 033-036
DOI: 10.1055/s-0033-1346974
Georg Thieme Verlag KG Stuttgart · New York

Positron Emission Tomography-Computed Tomography Coregistration for Diagnosis and Intraoperative Localization in Recurrent Nelson Syndrome

Eric B. Hintz
1   Department of Neurosurgery, University of Rochester School of Medicine, Rochester, New York, USA
,
Jeffery M. Tomlin
2   Department of Neurosurgery, Naval Medical Center San Diego, San Diego, California, USA
,
Vaseem Chengazi
3   Department of Radiology, University of Rochester School of Medicine, Rochester, New York, USA
,
G. Edward Vates
1   Department of Neurosurgery, University of Rochester School of Medicine, Rochester, New York, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

23. August 2012

25. Februar 2013

Publikationsdatum:
09. Mai 2013 (online)

   Lizenzen und Reprints

Abstract

Recurrent pituitary disease presents unique challenges, including in some cases difficulty localizing a tumor radiographically. Here, we present the case of a patient with recurrent Nelson syndrome whose radiographic work-up was complicated by a significant parasellar metallic artifact. Positron emission tomography ultimately localized the lesion, and coregistration with computed tomography allowed for accurate intraoperative navigation. Additionally, we review a range of imaging techniques available in the evaluation of pituitary disease.

Keywords

computed tomography - Nelson syndrome - pituitary adenoma - positron emission tomography
 

  • References

  • 1 Banasiak MJ, Malek AR. Nelson syndrome: comprehensive review of pathophysiology, diagnosis, and management. Neurosurg Focus 2007; 23 (3) E13
    PubMedGoogle Scholar
  • 2 Assié G, Bahurel H, Bertherat J, Kujas M, Legmann P, Bertagna X. The Nelson's syndrome... revisited. Pituitary 2004; 7 (4) 209-215
    CrossrefPubMedGoogle Scholar
  • 3 Kemink L, Pieters G, Hermus A, Smals A, Kloppenborg P. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease. J Clin Endocrinol Metab 1994; 79 (3) 887-889
    CrossrefPubMedGoogle Scholar
  • 4 Barber TM, Adams E, Ansorge O, Byrne JV, Karavitaki N, Wass JA. Nelson's syndrome. Eur J Endocrinol 2010; 163 (4) 495-507
    CrossrefPubMedGoogle Scholar
  • 5 Munir A, Newell-Price J. Nelson's Syndrome. Arq Bras Endocrinol Metabol 2007; 51 (8) 1392-1396
    CrossrefPubMedGoogle Scholar
  • 6 Dunn IF, Laws Jr ER. Transsphenoidal surgery for recurrent disease. In: Laws Jr. ER, Lanzino G, , eds. Transsphenoidal Surgery. Philadelphia, PA: Saunders; 2010: 192-199
    CrossrefGoogle Scholar
  • 7 Thapar K, Kovacs K, Muller PJ. Clinical-pathological correlations of pituitary tumours. Baillieres Clin Endocrinol Metab 1995; 9 (2) 243-270
    PubMedGoogle Scholar
  • 8 Buchfelder M, Schlaffer SM. Modern imaging of pituitary adenomas. Front Horm Res 2010; 38: 109-120
    PubMedGoogle Scholar
  • 9 Batista D, Courkoutsakis NA, Oldfield EH , et al. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease. J Clin Endocrinol Metab 2005; 90 (9) 5134-5140
    CrossrefPubMedGoogle Scholar
  • 10 Shellock FG, Spinazzi A. MRI safety update 2008: part 2, screening patients for MRI. AJR Am J Roentgenol 2008; 191 (4) 1140-1149
    CrossrefPubMedGoogle Scholar
  • 11 Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T. Incidence of intracranial aneurysm associated with pituitary adenoma. Neurosurg Rev 1997; 20 (1) 13-17
    CrossrefPubMedGoogle Scholar
  • 12 Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R. Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 2003; 98 (2) 350-358
    CrossrefPubMedGoogle Scholar
  • 13 Cook SW, Smith Z, Kelly DF. Endonasal transsphenoidal removal of tuberculum sellae meningiomas: technical note. Neurosurgery 2004; 55 (1) 239-244 , discussion 244–246
    CrossrefPubMedGoogle Scholar
  • 14 Fahlbusch R, Gerganov VM. Non-functional pituitary tumors. In: Kaye AH, Laws Jr. ER, , ed. Brain Tumors: An Encyclopedic Approach. Third Edition. Edinburg: Saunders; 2012: 672-691
    CrossrefGoogle Scholar
  • 15 Zimmerman RA. Imaging of intrasellar, suprasellar, and parasellar tumors. Semin Roentgenol 1990; 25 (2) 174-197
    CrossrefPubMedGoogle Scholar
  • 16 Syvertsen A, Haughton VM, Williams AL, Cusick JF. The computed tomographic appearance of the normal pituitary gland and pituitary microadenomas. Radiology 1979; 133 (2) 385-391
    PubMedGoogle Scholar
  • 17 Kulkarni MV, Lee KF, McArdle CB, Yeakley JW, Haar FL. 1.5-T MR imaging of pituitary microadenomas: technical considerations and CT correlation. AJNR Am J Neuroradiol 1988; 9 (1) 5-11
    PubMedGoogle Scholar
  • 18 van der Schaaf I, van Leeuwen M, Vlassenbroek A, Velthuis B. Minimizing clip artifacts in multi CT angiography of clipped patients. AJNR Am J Neuroradiol 2006; 27 (1) 60-66
    PubMedGoogle Scholar
  • 19 Moulik PK, Varma TR, Vora JP, Vinjamuri S. The role of somatostatin receptor scintigraphy in the management of pituitary tumours. Nucl Med Commun 2002; 23 (2) 117-120
    CrossrefPubMedGoogle Scholar
  • 20 van Royen EA, Verhoeff NP, Meylaerts SA, Miedema AR. Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands. J Nucl Med 1996; 37 (9) 1449-1451
    PubMedGoogle Scholar
  • 21 Warner RR, O'dorisio TM. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 2002; 32 (2) 79-83
    PubMedGoogle Scholar
  • 22 Acosta-Gómez MJ, Muros MA, Llamas-Elvira JM , et al. The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours. Br J Radiol 2005; 78 (926) 110-115
    CrossrefPubMedGoogle Scholar
  • 23 de Herder WW, Krenning EP, Malchoff CD , et al. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med 1994; 96 (4) 305-312
    CrossrefPubMedGoogle Scholar
  • 24 de Herder WW, Reijs AE, Feelders RA , et al. Diagnostic imaging of dopamine receptors in pituitary adenomas. Eur J Endocrinol 2007; 156 (Suppl. 01) S53-S56
    CrossrefPubMedGoogle Scholar
  • 25 Bergström M, Muhr C, Jossan S, Lilja A, Nyberg G, Långström B. Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-deprenyl. Neurosurgery 1992; 30 (6) 855-861
    CrossrefPubMedGoogle Scholar
  • 26 Taguchi T, Takao T, Iwasaki Y , et al. Diagnostic value of 18F-dihydroxyphenylalanine positron emission tomography for growth hormone-producing pituitary adenoma. Pituitary 2010; 13 (1) 78-79
    CrossrefPubMedGoogle Scholar
  • 27 Tang BN, Levivier M, Heureux M , et al. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas. Eur J Nucl Med Mol Imaging 2006; 33 (2) 169-178
    CrossrefPubMedGoogle Scholar
  • 28 De Souza B, Brunetti A, Fulham MJ , et al. Pituitary microadenomas: a PET study. Radiology 1990; 177 (1) 39-44
    PubMedGoogle Scholar
  • 29 Muhr C. Positron emission tomography in acromegaly and other pituitary adenoma patients. Neuroendocrinology 2006; 83 (3-4) 205-210
    CrossrefPubMedGoogle Scholar
  • 30 Jeong SY, Lee SW, Lee HJ , et al. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging 2010; 37 (12) 2334-2343
    CrossrefPubMedGoogle Scholar
  • 31 Hyun SH, Choi JY, Lee KH, Choe YS, Kim BT. Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med 2011; 52 (4) 547-550
    CrossrefPubMedGoogle Scholar
  • 32 Komori T, Martin WH, Graber AL, Delbeke D. Serendipitous detection of Cushing's disease by FDG positron emission tomography and a review of the literature. Clin Nucl Med 2002; 27 (3) 176-178
    CrossrefPubMedGoogle Scholar
  • 33 Bergström M, Muhr C, Lundberg PO, Långström B. PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 1991; 32 (4) 610-615
    PubMedGoogle Scholar
  • 34 Campeau RJ, David O, Dowling AM. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med 2003; 28 (4) 296-298
    PubMedGoogle Scholar
  • 35 Alzahrani AS, Farhat R, Al-Arifi A, Al-Kahtani N, Kanaan I, Abouzied M. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease. Pituitary 2009; 12 (4) 309-314
    CrossrefPubMedGoogle Scholar
  • 36 Ikeda H, Abe T, Watanabe K. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma. J Neurosurg 2010; 112 (4) 750-755
    CrossrefPubMedGoogle Scholar
  • 37 Pirotte B, Goldman S, Dewitte O , et al. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. J Neurosurg 2006; 104 (2) 238-253
    CrossrefPubMedGoogle Scholar
  • 38 Ewelt C, Floeth FW, Felsberg J , et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 2011; 113 (7) 541-547
    CrossrefPubMedGoogle Scholar
  • 39 Pirotte BJ, Lubansu A, Massager N , et al. Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors. J Neurosurg Pediatr 2010; 5 (5) 486-499
    CrossrefPubMedGoogle Scholar
  • 40 Yang S, Zhang C, Zhu T , et al. Resection of gliomas using positron emission tomography/computed tomography neuronavigation. Neurol Med Chir (Tokyo) 2007; 47 (9) 397-401 , discussion 402
    CrossrefPubMedGoogle Scholar